Company intelligence / Profile preview

Floxia

Paris, France

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Floxia is a French dermo-cosmetic company specializing in the development and commercialization of advanced skincare solutions for dermatological conditions. Founded in 2001, the company focuses on eight specific ranges targeting issues such as hyperpigmentation, acne, skin aging, and hair loss. Their products are formulated with high-quality active ingredients and are distributed globally through pharmacies and dermatological clinics. Floxia positions itself at the intersection of medicine and cosmetics, providing clinical-grade topical treatments for sensitive and problematic skin.

Therapeutic areas: Dermatology
Modalities: Small moleculePeptidesTopical formulation
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Floxia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Floxia.

Explore the full profile